research

Showing 15 posts of 110 posts found.

msd

Merck & Co says study shows significantly higher persistence for its arthritis drug Simponi

March 17, 2016
Research and Development, Sales and Marketing Merck & Co, drug trial, research, rheumatoid arthritis

US pharma giant Merck & Co (NYSE: MRK) said its rheumatoid arthritis drug showed significantly higher persistence compared with other drugs …

shutterstock_95714119

Vitae Pharma soars on positive mid-stage trial results for psoriasis drug

March 17, 2016
Business Services, Research and Development, Sales and Marketing Vitae Pharmaceuticals, drug trial, psoriasis, research

Shares in Vitae Pharmaceuticals (Nasdaq: VTAE) nearly doubled in pre-market trading Thursday after the company reported mid-stage trials of its psoriasis …

rd_hands

Shares in Celldex halve in value as it discontinues trial of brain cancer drug

March 8, 2016
Manufacturing and Production, Research and Development Cancer, Celldex, research

Shares in Celldex Therapeutics (Nasdaq: CLDX) more than halved in value on the Nasdaq Monday as the company said independent regulators …

The future for pharma packaging

March 1, 2016
Manufacturing and Production distribution, packaging, research, supply chain

The pharmaceutical packaging market is projected for strong growth through 2020, driven by innovation for new products and materials and …

Elias Zerhouni

Sanofi seals double oncology research deals

January 11, 2016
Research and Development, Sales and Marketing Sanofi, Warp Drive Bio, antibodies, collaboration, immuno-oncology, research

Sanofi has signed two separate research agreements for €1.2 billion, which will give the French firm licensing rights to potential …

Janssen image

Janssen, Enterome and Kymab in research collaborations

January 7, 2016
Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research

Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …

Alzheimer's brain

The case for adaptive trials in dementia

January 6, 2016
Manufacturing and Production, Research and Development Alzheimer's, Alzheimer's disease, adaptive trials, research

An ageing population and widespread chronic neuro-degenerative disease will make dementia an ever increasing burden on society, families and the …

National Institutes of Health building

Clinical trials increasingly funded by pharma industry

December 17, 2015
Research and Development JAMA, Journal of the American Medical Association, NIH, National Institutes of Health, clinical trials, clinicaltrials.gov, pharma, research

The number of clinical trials funded by pharma has risen significantly since 2006, while the number funded by the US …

Westminster

Pharma leaders urge UK Government not to cut spending

September 9, 2015
Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding

Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …

NICE reworks cancer guidance for GPs

June 23, 2015
Sales and Marketing Cancer, GPs, NICE, UK, baker, research

The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …

Dementia image

UK government spends £300 million on dementia

February 23, 2015
Research and Development, Sales and Marketing Cameron, England, NHS, dementia, investment, research

UK prime minister David Cameron has said the government is to invest more than £300m into dementia research and that …

research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014
Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …

Stevenage Bioscience Catalyst campus image

Cell Therapy Catapult to build £55 million bioscience campus

December 17, 2014
Research and Development, Sales and Marketing Cell Therapy Catapult, UK, bioscience, research, stevenage

UK firm The Cell Therapy Catapult has chosen to build a £55 million state-of-the-art cell therapy manufacturing centre in Stevenage. …

UK government and partners pay £230m for disease research

October 23, 2014
Research and Development, Sales and Marketing Arthritis Research UK, British Heart Foundation, Cancer Research UK, London, MRC, Osborne, UK, Wellcome Trust, dementia, research

A new partnership led by the Medical Research Council and the UK government will invest over £230 million in a …

Boris image

Mayor of London calls for dementia R&D centre

October 8, 2014
Research and Development, Sales and Marketing Alzheimer's, Boris Johnson, London, dementia, research

The mayor of London Boris Johnson is calling on both the government and the private sector to come together and …

The Gateway to Local Adoption Series

Latest content